SCHEMBL15538437

SCHEMBL15538437

COC(=O)c1ccc(-c2ccc(OCC3CCN(CC(C)(C)F)CC3)c(F)c2)cn1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 8/20 0.44
WNT1 P04628 3/20 0.44
GSK3B P49841 3/20 0.41
RBP4 P02753 3/20 0.40
GPR119 Q8TDV5 3/20 0.40
NAAA Q02083 1/20 0.40
FFAR4 Q5NUL3 1/20 0.39
TTR P02766 2/20 0.38
GRIN1 Q05586 1/20 0.38
GRIN2B Q13224 1/20 0.38
SCN7A Q01118 1/20 0.36
SCN5A Q14524 1/20 0.36
TLR9 Q9NR96 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539556 0.91 DYRK1A (0.43) DYRK1AWNT1GSK3BRBP4GPR119
SCHEMBL15537941 0.89 XDH (0.44) DYRK1AWNT1
SCHEMBL20053618 0.88 DYRK1A (0.41) DYRK1AWNT1GSK3BRBP4
SCHEMBL15538824 0.87 CHRM2 (0.42) DYRK1AWNT1GSK3BRBP4GPR119
SCHEMBL15538921 0.87 CHRM4 (0.43) DYRK1AWNT1GSK3BRBP4FFAR4
SCHEMBL15538802 0.86 GPR119 (0.44) DYRK1AWNT1GSK3BGPR119
SCHEMBL15538171 0.85 DYRK1A (0.40) DYRK1AWNT1GSK3BGPR119
SCHEMBL15539453 0.85 WNT1 (0.41) DYRK1AWNT1GSK3BRBP4GPR119
SCHEMBL15539229 0.83 KMT2A (0.41) DYRK1AWNT1GSK3BRBP4
SCHEMBL15539227 0.83 KMT2A (0.41) DYRK1AWNT1GSK3BRBP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 DYRK1A 1804/4885WNT1 3742/4885GSK3B 4232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.